An Engineered Ferritin Nanocage Co-Delivery System for Targeted Hair Cells Protection and Hearing Loss Attenuation
July 2026
in “
Theranostics
”
Studysummary This study developed a novel ferritin-based delivery system (LR@Fn) that effectively co-delivers RG108 and LLY283 for hearing loss treatment in animal models, reducing hair cell loss and synaptic damage more effectively than dexamethasone.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on thno.org →